808 filings
Page 12 of 41
DEFA14A
l4yv4a
14 Jul 17
Additional proxy soliciting materials
12:00am
SC 13D/A
4l6b69cpsm9
14 Jul 17
Peregrine Pharmaceuticals Inc
12:00am
8-K
pmoe1ag
14 Jul 17
Results of Operations and Financial Condition
12:00am
DFAN14A
hs1x6
13 Jul 17
Additional proxy materials by non-management
12:00am
8-K
apaj3
7 Jul 17
Peregrine Pharmaceuticals Announces Reverse Stock Split
12:00am
SC 13D/A
lwf29ceh
29 Jun 17
Peregrine Pharmaceuticals Inc
12:00am
SC 13D/A
1mjw7xno6
20 Jun 17
Peregrine Pharmaceuticals Inc
12:00am
8-K
tnisi4 nnxb
7 Jun 17
Other Events
12:00am
8-K
aupci
6 Jun 17
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible
12:00am
SC 13D/A
k5sl4x
19 May 17
Peregrine Pharmaceuticals Inc
12:00am
4
ttoa8ev
28 Apr 17
PEREGRINE PHARMACEUTICALS / Joseph Shan ownership change
12:00am
4
lvjergyr8k4u3hl4zd
28 Apr 17
PEREGRINE PHARMACEUTICALS / STEVEN W KING ownership change
12:00am
4
xzl373chpuu84x
28 Apr 17
PEREGRINE PHARMACEUTICALS / PAUL J LYTLE ownership change
12:00am
SC 13D
0lic3 vlh1kl
17 Apr 17
Peregrine Pharmaceuticals Inc
12:00am
8-K
sbhdl2
12 Apr 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
8hge2bfet5iptgp
13 Mar 17
Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2017 and Recent Developments
12:00am
SC 13D/A
5p7mhiazhmzty3zs1
10 Mar 17
Peregrine Pharmaceuticals Inc
12:00am
8-K
hh50set
9 Mar 17
Other Events
12:00am